BriaCell Interest Income from 2010 to 2026

BCTXW Stock

USD 0.01 0.0009 10.11%

BriaCell Therapeutics Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income will likely drop to about 177.7 K in 2026. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-10-31

Previous Quarter

26.6 K

Current Value

48.5 K

Quarterly Volatility

82.2 K

Covid

Interest Hikes

Check BriaCell Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BriaCell Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 178.6 K, Interest Expense of 48.5 K or Other Operating Expenses of 45.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.19. BriaCell financial statements analysis is a perfect complement when working with BriaCell Therapeutics Valuation or Volatility modules.

Build AI portfolio with BriaCell Stock

Check out the analysis of BriaCell Therapeutics Correlation against competitors.

The evolution of Interest Income for BriaCell Therapeutics Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how BriaCell Therapeutics compares to historical norms and industry peers.

Latest BriaCell Therapeutics' Interest Income Growth Pattern

Below is the plot of the Interest Income of BriaCell Therapeutics Corp over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. BriaCell Therapeutics' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BriaCell Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

BriaCell Interest Income Regression Statistics

	Arithmetic Mean	143,449
	Geometric Mean	53,546
	Coefficient Of Variation	154.18
	Mean Deviation	148,107
	Median	37,590
	Standard Deviation	221,175
	Sample Variance	48.9B
	Range	888.7K
	R-Value	0.54
	Mean Square Error	36.9B
	R-Squared	0.29
	Significance	0.02
	Slope	23,700
	Total Sum of Squares	782.7B

BriaCell Interest Income History

	2026	177.7 K
	2025	331.2 K
	2023	288 K
	2022	891.2 K
	2021	136.7 K
	2020	3149.0
	2019	54 K

Other Fundumenentals of BriaCell Therapeutics

Net Interest Income

BriaCell Therapeutics Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Net Receivables	Short Term Investments	Intangible Assets	Common Stock	Current Deferred Revenue	Net Invested Capital	Long Term Investments	Net Working Capital	Long Term Debt	Short Long Term Debt	Capital Stock	Short Term Debt
Total Assets		0.8	-0.95	-0.43	0.21	0.49	0.99	0.21	0.67	0.47	0.55	-0.51	0.69	0.21	0.82	-0.64	-0.6	0.7	-0.6
Total Stockholder Equity	0.8		-0.69	-0.39	0.29	-0.11	0.77	0.18	0.5	0.29	0.57	-0.34	0.71	0.39	0.48	-0.44	-0.41	0.47	-0.41
Net Debt	-0.95	-0.69		0.19	0.01	-0.49	-0.96	0.0	-0.54	-0.44	-0.31	0.44	-0.8	0.04	-0.95	0.55	0.51	-0.56	0.51
Retained Earnings	-0.43	-0.39	0.19		-0.86	-0.36	-0.42	-0.85	-0.79	-0.47	-0.96	0.62	0.21	-0.89	0.09	0.74	0.71	-0.85	0.71
Accounts Payable	0.21	0.29	0.01	-0.86		0.12	0.19	0.96	0.67	0.35	0.83	-0.5	-0.23	0.96	-0.27	-0.61	-0.58	0.73	-0.58
Total Liab	0.49	-0.11	-0.49	-0.36	0.12		0.51	0.27	0.51	0.41	0.29	-0.45	-0.06	0.0	0.5	-0.52	-0.49	0.59	-0.49
Total Current Assets	0.99	0.77	-0.96	-0.42	0.19	0.51		0.2	0.69	0.51	0.55	-0.55	0.7	0.19	0.84	-0.66	-0.62	0.7	-0.62
Net Receivables	0.21	0.18	0.0	-0.85	0.96	0.27	0.2		0.69	0.37	0.79	-0.52	-0.28	0.88	-0.22	-0.63	-0.6	0.77	-0.6
Short Term Investments	0.67	0.5	-0.54	-0.79	0.67	0.51	0.69	0.69		0.67	0.81	-0.78	0.16	0.64	0.31	-0.91	-0.88	0.86	-0.88
Intangible Assets	0.47	0.29	-0.44	-0.47	0.35	0.41	0.51	0.37	0.67		0.48	-0.98	0.21	0.31	0.31	-0.8	-0.81	0.58	-0.81
Common Stock	0.55	0.57	-0.31	-0.96	0.83	0.29	0.55	0.79	0.81	0.48		-0.62	-0.04	0.89	0.01	-0.74	-0.71	0.83	-0.71
Current Deferred Revenue	-0.51	-0.34	0.44	0.62	-0.5	-0.45	-0.55	-0.52	-0.78	-0.98	-0.62		-0.15	-0.46	-0.27	0.88	0.89	-0.7	0.89
Net Invested Capital	0.69	0.71	-0.8	0.21	-0.23	-0.06	0.7	-0.28	0.16	0.21	-0.04	-0.15		-0.24	0.82	-0.18	-0.15	0.15	-0.15
Long Term Investments	0.21	0.39	0.04	-0.89	0.96	0.0	0.19	0.88	0.64	0.31	0.89	-0.46	-0.24		-0.34	-0.56	-0.54	0.67	-0.54
Net Working Capital	0.82	0.48	-0.95	0.09	-0.27	0.5	0.84	-0.22	0.31	0.31	0.01	-0.27	0.82	-0.34		-0.34	-0.3	0.35	-0.3
Long Term Debt	-0.64	-0.44	0.55	0.74	-0.61	-0.52	-0.66	-0.63	-0.91	-0.8	-0.74	0.88	-0.18	-0.56	-0.34		1.0	-0.84	1.0
Short Long Term Debt	-0.6	-0.41	0.51	0.71	-0.58	-0.49	-0.62	-0.6	-0.88	-0.81	-0.71	0.89	-0.15	-0.54	-0.3	1.0		-0.8	1.0
Capital Stock	0.7	0.47	-0.56	-0.85	0.73	0.59	0.7	0.77	0.86	0.58	0.83	-0.7	0.15	0.67	0.35	-0.84	-0.8		-0.8
Short Term Debt	-0.6	-0.41	0.51	0.71	-0.58	-0.49	-0.62	-0.6	-0.88	-0.81	-0.71	0.89	-0.15	-0.54	-0.3	1.0	1.0	-0.8

Click cells to compare fundamentals

About BriaCell Therapeutics Financial Statements

BriaCell Therapeutics investors use historical fundamental indicators, such as BriaCell Therapeutics' Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BriaCell Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	331.2 K	177.7 K
Net Interest Income	259.2 K	272.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for BriaCell Stock Analysis

When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

BriaCell Interest Income from 2010 to 2026

Latest BriaCell Therapeutics' Interest Income Growth Pattern

BriaCell Interest Income Regression Statistics

BriaCell Interest Income History

Other Fundumenentals of BriaCell Therapeutics

BriaCell Therapeutics Interest Income component correlations

About BriaCell Therapeutics Financial Statements

Also Currently Popular

Additional Tools for BriaCell Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY